Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trial.
- Conditions
- Retained placenta
- Registration Number
- NL-OMON20129
- Lead Sponsor
- Giel van Stralen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. All women with at least 25 completed pregnancy weeks and retained placenta;
2. At least 18 years of age;
3. Master the Dutch language in word and script.
Exclusion Criteria
1. Excessive blood loss (>1000 ml) within 60 minutes after the delivery of the newborn;
2. Allergy for misoprostol or one of its components.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number of spontaneous delivered placentas;<br>2. Number of manual removals and amount of blood loss.
- Secondary Outcome Measures
Name Time Method 1. Interval between delivery of the baby and administration of misoprostol;<br>2. Interval between administration of misoprostol and delivery of the placenta;<br>3. Placenta captiva.